James Kihara - Net Worth and Insider Trading
James Kihara Net Worth
The estimated net worth of James Kihara is at least $212,532 dollars as of 2024-05-17. James Kihara is the PRINCIPAL ACCOUNTING OFFICER of ACADIA Pharmaceuticals Inc and owns about 14,370 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $212,532. Details can be seen in James Kihara's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Kihara has not made any transactions after 2024-05-02 and currently still holds the listed stock(s).
Transaction Summary of James Kihara
James Kihara Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Kihara owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .
Click here to see the complete history of James Kihara’s form 4 insider trades.
Insider Ownership Summary of James Kihara
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-05-02 | Principal Accounting Officer |
James Kihara Latest Holdings Summary
James Kihara currently owns a total of 1 stock. James Kihara owns 14,370 shares of ACADIA Pharmaceuticals Inc (ACAD) as of May 2, 2024, with a value of $212,532.
Latest Holdings of James Kihara
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2024-05-02 | 14,370 | 14.79 | 212,532 |
Holding Weightings of James Kihara
James Kihara Form 4 Trading Tracker
According to the SEC Form 4 filings, James Kihara has made a total of 13 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 1,326 shares on May 2, 2024, which brought James Kihara around $22,462.
Insider Trading History of James Kihara
- 1
James Kihara Trading Performance
James Kihara Ownership Network
James Kihara Owned Company Details
What does ACADIA Pharmaceuticals Inc do?
Who are the key executives at ACADIA Pharmaceuticals Inc?
James Kihara is the Principal Accounting Officer of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .
ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary
Over the past 18 months, James Kihara made 11 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 19,096. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 312,332 shares made by Stephen Davis , a net sale of 35,661 shares made by Brendan Teehan , and a net sale of 46,310 shares made by Mark C. Schneyer .
In summary, during the past 3 months, insiders sold 89,116 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 89,116 shares. During the past 18 months, 452,970 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 443,552 shares.
ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.
ACADIA Pharmaceuticals Inc Insider Transactions
James Kihara Mailing Address
Above is the net worth, insider trading, and ownership report for James Kihara. You might contact James Kihara via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
